Compare Stocks: IONS vs. PRAX vs. AXSM vs. ABVX
Compare normalized stock price performance over 6 months, 1 year or 2 years. Each line starts at 0%, so different stock prices can be compared on the same scale.
IONSPRAXAXSMABVX
Market Snapshot
Current market context for the selected companies.
IONS
$63.12
Market Cap
$10.53B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-27
PRAX
$372.19
Market Cap
$10.54B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-27
AXSM
$204.93
Market Cap
$10.85B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-27
ABVX
$116.31
Market Cap
10.17B
Sector
Healthcare
Industry
Biotechnology
Data through
2026-08-27
Performance
Absolute returns and relative performance versus SPY.
| Metric | IONS | PRAX | AXSM | ABVX |
|---|---|---|---|---|
| 1 Month | +16.8% | +27.9% | -9.9% | -2.1% |
| 1 Month vs SPY | +11.2% | +22.2% | -15.5% | -7.8% |
| 3 Months | -18.4% | +5.5% | -12.0% | -10.2% |
| 3 Months vs SPY | -20.5% | +3.4% | -14.1% | -12.3% |
| 6 Months | -21.7% | +9.3% | +25.6% | -2.6% |
| 6 Months vs SPY | -33.5% | -2.5% | +13.8% | -14.4% |
| 1 Year | +49.7% | +677.0% | +69.2% | +45.9% |
| 1 Year vs SPY | +30.2% | +657.6% | +49.7% | +26.5% |
| 2 Years | +32.8% | +648.0% | +135.3% | +897.6% |
| 2 Years vs SPY | -5.8% | +609.4% | +96.7% | +859.0% |
Growth & Profitability
Operating growth, margins and capital efficiency.
Valuation
Common valuation multiples shown side by side.
Cash Flow & Balance Sheet
Cash generation and leverage context.
Earnings Outlook
Upcoming earnings expectations when available.